CLINICAL_TRIALS ClinicalTrials.gov record update

Beyond Baseline Frailty Screening: Longitudinal Geriatric Vulnerability, Severe Chemotherapy Toxicity, and Functional Decline in Older Adults With Nonmetastatic Gastrointestinal Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07184047
Title field or adapter rule: {'original_value': 'Beyond Baseline Frailty Screening: Longitudinal Geriatric Vulnerability, Severe Chemotherapy Toxicity, and Functional Decline in Older Adults With Nonmetastatic Gastrointestinal Cancer', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At: 2026-10-31T23:27:23.275305+00:00
Published At: 2026-10-16T00:00:00+00:00
Record Updated At: 2026-10-16
Source Retrieved At: 2026-10-31T22:17:52.415050+00:00
Timestamp Basis: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

protocolSection.conditionsModule.conditions: ["Gastrointestinal Cancers", "Frailty", "Sarcopenia in Elderly", "Malnutrition Elderly", "Toxicity Due to Chemotherapy", "Colorectal Cancer", "Gastric Cancer (GC)", "Pancreatic Cancer Resectable", "Biliary Tract Cancer", "Esophageal Cancer (EsC)", "Older Adults (65 Years and Older)"]
protocolSection.statusModule.lastUpdatePostDateStruct: {"date": "2026-10-16", "type": "ACTUAL"}
protocolSection.identificationModule.nctId: "NCT07184047"
protocolSection.identificationModule.officialTitle: "Beyond Baseline Frailty Screening: Longitudinal Geriatric Vulnerability, Severe Chemotherapy Toxicity, and Functional Decline in Older Adults With Nonmetastatic Gastrointestinal Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: null
protocolSection.statusModule.resultsFirstPostDateStruct: null

{'armGroupLabels': ['Adjuvant and Neoadjuvant Chemotherapy Cohort'], 'description': 'Participants receive standard-of-care adjuvant or neoadjuvant chemotherapy for nonmetastatic or locally advanced gastrointestinal cancer, as determined by the treating oncologist according to tumor characteristics, disease stage, treatment intent, and established clinical practice. Chemotherapy regimens may include CAPOX, FOLFOX, capecitabine monotherapy, modified FOLFIRINOX, gemcitabine monotherapy, FLOT, or gemcitabine plus capecitabine, as clinically appropriate. Treatment selection, dosing, modifications, and supportive care are not assigned or directed by the study. The observational assessments do not involve any experimental drugs or investigational therapeutic interventions.', 'name': 'Standard-of-Care Systemic Chemotherapy', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.